Not the PR I was looking for...
TapImmune Sponsors 26.2 With DONNA Marathon for Breast Cancer Research and Care
PR Newswire TapImmune Inc.
55 minutes ago
????
JACKSONVILLE, Florida, February 10, 2016 /PRNewswire/ --
Events & Marathon to take place in Jacksonville, Florida on February 12-14, 2016
TapImmune, Inc. (TPIV), a clinical-stage onco-immunology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, today announced the Company is a proud sponsor of 26.2 with DONNA , a non-profit organization dedicated to funding groundbreaking breast cancer research and providing assistance to women and men who have been diagnosed with breast cancer. 26.2 with DONNA produces the only marathon in the U.S. dedicated to this cause. In the October issue of Women's Running Magazine, WR readers voted 26.2 with DONNA their single favorite charity race. In addition, CNN recently voted 26.2 with DONNA the 7th best run in the nation.
Events of this marathon weekend will take place on February 12-14, 2016 in Jacksonville, Florida. TapImmune is sponsoring the Marathon Expo on February 12-13 and will co-sponsor the marathon reception on the evening of February 12. In addition to TapImmune, sponsors include Amgen, Celgene, Genentech and companies from a broad range of industries who support breast cancer research and patient care.
"We are very proud to sponsor and support the 26.2 DONNA Marathon. Funds from DONNA events have made a significant contribution to the advancement of breast cancer research at the Mayo Clinic. We believe that by bringing industry, charitable organizations and non-profits together with public funding we can greatly facilitate the common aim to cure breast cancer," stated Dr. Glynn Wilson Chairman & CEO of TapImmune.
About 26.2 with DONNA
